Amiloride derivatives block ion channel activity and enhancement of virus-like particle budding caused by HIV-1 protein Vpu

被引:88
作者
Ewart, GD
Mills, K
Cox, GB
Gage, PW
机构
[1] Australian Natl Univ, Biotron Ltd, Canberra, ACT 2601, Australia
[2] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia
来源
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS | 2002年 / 31卷 / 01期
关键词
human immunodeficiency virus; Vpu protein; amiloride derivatives; ion channels;
D O I
10.1007/s002490100177
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The Vpu protein of human immunodeficiency virus type I forms cation-selective ion channels and enhances the process of virion budding and release. Mutagenesis studies have shown that the N-terminal transmembrane domain primarily controls both of these activities. Here we report that the Vpu ion channel is inhibited by the amiloride derivatives 5-(N,N-hexamethylene)amiloride and 5-(N,N-dimethyl)amiloride but not by amiloride itself, nor by amantadine. Hexamethyleneamiloride also inhibits budding of virus-like particles from HeLa cells expressing HIV-1 Gag and Vpu proteins. These results confirm the link between Vpu ion channel activity and the budding process and also suggest that amiloride derivatives might have useful anti-HIV-1 properties.
引用
收藏
页码:26 / 35
页数:10
相关论文
共 39 条
[21]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VPU PROTEIN IS AN OLIGOMERIC TYPE-I INTEGRAL MEMBRANE-PROTEIN [J].
MALDARELLI, F ;
CHEN, MY ;
WILLEY, RL ;
STREBEL, K .
JOURNAL OF VIROLOGY, 1993, 67 (08) :5056-5061
[22]   Chronology of genetic changes in the vpu, env, and nef genes of chimeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques [J].
McCormick-Davis, C ;
Zhao, LJ ;
Mukherjee, S ;
Leung, K ;
Sheffer, D ;
Joag, SV ;
Narayan, O ;
Stephens, EB .
VIROLOGY, 1998, 248 (02) :275-283
[23]   Comparison of Vpu sequences from diverse geographical isolates of HIV type 1 identifies the presence of highly variable domains, additional invariant amino acids, and a signature sequence motif common to subtype C isolates [J].
McCormick-Davis, C ;
Dalton, SB ;
Singh, DK ;
Stephens, EB .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (11) :1089-1095
[24]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF AMILORIDE AND ITS ANALOGS IN RAT PLASMA [J].
MENG, QC ;
CHEN, YF ;
OPARIL, S ;
CRAGOE, EJ .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1990, 529 (01) :201-209
[25]  
Miller C., 1986, ION CHANNEL RECONSTI
[26]   MACROPHAGE-TROPIC HIV - CRITICAL FOR AIDS PATHOGENESIS [J].
MOSIER, D ;
SIEBURG, H .
IMMUNOLOGY TODAY, 1994, 15 (07) :332-339
[27]   Mutational analysis of the human immunodeficiency virus type 1 Vpu transmembrane domain that promotes the enhanced release of virus-like particles from the plasma membrane of mammalian cells [J].
Paul, M ;
Mazumder, S ;
Raja, N ;
Jabbar, MA .
JOURNAL OF VIROLOGY, 1998, 72 (02) :1270-1279
[28]   Vpr protein of human immunodeficiency virus type 1 forms cation-selective channels in planar lipid bilayers [J].
Piller, SC ;
Ewart, GD ;
Premkumar, A ;
Cox, GB ;
Gage, PW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (01) :111-115
[29]   INFLUENZA-VIRUS M2 PROTEIN HAS ION CHANNEL ACTIVITY [J].
PINTO, LH ;
HOLSINGER, LJ ;
LAMB, RA .
CELL, 1992, 69 (03) :517-528
[30]   The ion channel activity of the influenza virus M(2) protein affects transport through the Golgi apparatus [J].
Sakaguchi, T ;
Leser, GP ;
Lamb, RA .
JOURNAL OF CELL BIOLOGY, 1996, 133 (04) :733-747